| Ytd | 2.43% | |
| 1y | 61.02% |
| Open | 23.89 | Prev Close | 23.83 | Low | 23.76 | High | 24.58 | Mkt Cap | 3.07B |
| Vol | 795.19K | Avg Vol | 1.34M | EPS | -3.91 | P/E | N/A | Forward P/E | -7.48 |
| Beta | 0.94 | Short Ratio | 9.41 | Inst. Own | 74.91% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-27 | 50-d Avg | 27.47 | 200-d Avg | 24.82 | 1yr Est | 39.91 |
HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biop
Wedbush analyst Robert Driscoll reiterates Arcus Biosciences (NYSE:RCUS) with a Outperform and ma
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) stock moved upwards by 44.6% to $2.4 during Monday&